Clinical Trial Update: Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating fulvestrant with or without vandetanib in advanced aromatase inhibitor–resistant breast cancer, sponsored by Velindre NHS Trus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Vandetanib (vandetanib)

Snippet

Sponsor: Velindre NHS Trust | Conditions: Neoplasms | Phase 2 | Status: UNKNOWN